Fusion Genes in Childhood Acute Lymphoblastic Leukemia and Its Clinical Significance

ZHU Xiao-hua,GAO Yi-jin,YANG Yi,WU Yue

DOI: https://doi.org/10.3969/j.issn.1000-3606.2007.08.007

2007-01-01

Abstract:Objectives To establish reverse transcription and nest polymerase chain reaction method to detect expression of four fusion genes in childhood acute lymphoblastic leukemia(ALL),and analyze the clinical characters of the patients with positive fusion genes.Methods Reverse transcription and nest polymerase chain reaction proce-dure was set up and four of the most frequent fusion genes in pediatric ALL,such as TEL/AML1,E2A/PBX1,m-BCR/ABL and AF4/MLL fusion transcripts were examined in bone marrow from 92 newly diagnosed childhood ALL patients.Results TEL-AML1 fusion gene was found in 21 out of 92 cases,accounting for 24.7% in childhood B lineage ALL patients.No statistical difference was found in age,complete remission(CR)rate within 15 days and early death rate between the positive and negative TEL/AML ALL patients,while the initial WBC count was lower in positive cases.The incidence of E2A/PBX1 fusion gene was 6.5% in childhood ALL(6/92).Only one case with positive m-BCR/ABL fusion gene was detected(1.1%).Moreover,two patients with positive AF4/MLL were found among 6 cases of infant ALL(33.3%).Conclusions Compared with RT-PCR,nested RT-PCR technology is more specific and sensitive to detect fusion genes as targets for molecular classification of childhood ALL at diagnosis.TEL/AML1 fusion gene is the most common molecular aberration in childhood ALL,and positive patients show lower peripheral tumor load at diagnosis.Both TEL/AML1 and E2A/PBX1 fusion transcripts are the most frequently occurred in pediatric B lineage ALL.